Le Lézard
Classified in: Science and technology
Subject: MAT

Clubhouse Media Group, Inc. Announces Vivi Acevedo, International Model, Joins HoneyDrip.com


LOS ANGELES, Nov. 22, 2023 /PRNewswire/ -- Clubhouse Media Group, Inc. (OTCMKTS: CMGR) ("Clubhouse Media Group"), a social media firm and digital agency, today announced that international model and social media influencer, Vivi Acevedo, has joined HoneyDrip.com. Vivi has a large following, boasting 180K+ followers on Instagram alone. HoneyDrip.com is a digital platform designed and wholly owned by CMGR with a focus on the empowerment of creators. The site allows creators to connect and engage with fans and monetize exclusive content.

"Vivi (like many of our professional creators) has a large following of fans that we anticipate following her on HoneyDrip.com and increasing traffic to the site," said Alexandra Bolanos, Manager at HoneyDrip.com. "Many of our fans build strong relationships with their favorite creators, and the site has allowed them to connect and interact directly via chat and video."

Creators can apply to join at HoneyDrip.com

Visit us at www.clubhousemediagroup.com

About Clubhouse Media Group, Inc.
CMGR offers management, production, and deal-making services to its handpicked influencers, a management division for individual influencer clients, and an investment arm for joint ventures and acquisitions for companies in the social media influencer space.

FORWARD-LOOKING STATEMENTS: This release contains "forward-looking statements". Forward-looking statements also may be included in other publicly available documents issued by CMGR and in oral statements made by our officers and representatives from time to time. These forward-looking statements are intended to provide management's current expectations or plans for our future operating and financial performance, based on assumptions currently believed to be valid. They can be identified by the use of words such as "anticipate," "intend," "plan," "goal," "seek," "believe," "project," "estimate," "expect," "strategy," "future," "likely," "may," "should," "would," "could," "will" and other words of similar meaning in connection with a discussion of future operating or financial performance.

Examples of forward-looking statements include, among others, statements relating to future sales, earnings, cash flows, results of operations, uses of cash and other measures of financial performance.

Because forward-looking statements relate to the future, they are subject to inherent risks, uncertainties and other factors that may cause CMGR's actual results and financial condition to differ materially from those expressed or implied in the forward-looking statements. Such risks, uncertainties and other factors include, among others such as, but not limited to economic conditions, changes in the laws or regulations, demand for CMGR's products and services, the effects of competition and other factors that could cause actual results to differ materially from those projected or represented in the forward-looking statements. Any forward-looking information provided in this release should be considered with these factors in mind. We caution investors not to rely unduly on any forward-looking statements and urge you to carefully consider the risks described in our filings with the Securities and Exchange Commission from time to time, including our most recent Annual Report on Form 10-K and subsequent Quarterly Reports on Forms 10-Q and Current Reports on Form 8-K, which are available on the Securities and Exchange Commission's website at sec.gov. We assume no obligation to update any forward-looking statements contained in this press release.

SOURCE Clubhouse Media Group, Inc


These press releases may also interest you

15 fév 2025
Samsung Bioepis Co., Ltd. today announced that the European Commission (EC) has granted marketing authorization for OBODENCEtm (60mg pre-filled syringe) and XBRYKtm (120mg vial), denosumab biosimilars referencing Prolia and Xgeva ? formerly referred...

15 fév 2025
Arcus Biosciences, Inc. , a clinical-stage, global biopharmaceutical company focused on developing differentiated molecules and combination therapies for people with cancer, today presented new data for casdatifan, a HIF-2a inhibitor with...

15 fév 2025
Aquiline Drones Embarks on Nationwide Campaign ? Using Disruptive Technologies: Drones and AI cameras to Fight Unsightly Graffiti. Unsightly graffiti is a menace to communities and metropolises, worldwide! More than just a nuisance, graffiti is a...

15 fév 2025
Exelixis, Inc. today announced final results from the phase 3 CheckMate -9ER pivotal trial evaluating CABOMETYX® (cabozantinib) in combination with Opdivo® (nivolumab) versus sunitinib for patients with previously untreated advanced renal cell...

15 fév 2025
Florida Atlantic University has officially established itself among the most prestigious colleges and universities in the United States for its notable accomplishments in research. It now holds the esteemed designation of "R1: Very High Research...

15 fév 2025
Sigenergy, a leading energy innovator, hosted an exclusive event on February 14 in Johannesburg to highlight its groundbreaking commercial and industrial (C&I) energy storage solutions. The event featured a real-world case study that showcased the...



News published on and distributed by: